title: Effect of nucleoside analogues and oligonucleotides on hydrolysis of liposomal phospholipids.
abstract: The hydrolysis of the bilayer forming phospholipids resulting first of all in lysophospholipids and fatty acids is one limiting factor determining the shelf-life of liposomes. In several studies the influence of pH, buffer, lipid composition and other parameters on the hydrolysis of phospholipids have been demonstrated, but the influence of drugs has not yet been investigated systematically. In this study the influence of nucleoside analogues, especially 2', 2'-difluoro 2'-deoxycytidine (gemcitabine, dFdC) on the degradation of phospholipids was elucidated in more detail. It could be demonstrated that the interaction of dFdC with phospholipid bilayers promotes the hydrolysis of phospholipids in a concentration-dependent manner. Obviously two parts of the molecule, the amino group bound to the pyrimidine moiety and the 2', 2'-difluoro-2'-deoxyribose, seem to be responsible for the forced phospholipid hydrolysis. The dFdC-induced hydrolysis of phospholipids was influenced by pH, buffer, lipid composition and different anions. Optimization of the above parameters resulted in prolonged shelf-life of dFdC liposome dispersions, which is an important prerequisite for clinical practice.
authors.affiliation: Tumor Biology Center, Department of Clinical Research, Breisacher Strasse 117, 79106, Freiburg, Germany. reginam@farmasi.uit.no
authors.forename: R
authors.initials: R
authors.lastname: Moog
authors.forename: M
authors.initials: M
authors.lastname: Brandl
authors.forename: R
authors.initials: R
authors.lastname: Schubert
authors.forename: C
authors.initials: C
authors.lastname: Unger
authors.forename: U
authors.initials: U
authors.lastname: Massing
mesh_terms: D000838:Anions; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D002021:Buffers; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D008051:Lipid Bilayers / Q000378:metabolism*; D008081:Liposomes; D008246:Lysophospholipids / Q000008:administration & dosage* / Q000737:chemistry; D009705:Nucleosides / Q000008:administration & dosage* / Q000737:chemistry; D009841:Oligonucleotides / Q000008:administration & dosage* / Q000737:chemistry; D000093542:Gemcitabine
chemical_list: D000838:Anions; D000964:Antimetabolites, Antineoplastic; D002021:Buffers; D008051:Lipid Bilayers; D008081:Liposomes; D008246:Lysophospholipids; D009705:Nucleosides; D009841:Oligonucleotides; D003841:Deoxycytidine; D000093542:Gemcitabine